









Markets
/
Stocks
/
nasdaq-antx
/

AN2 Therapeutics Inc

ANTX

1.120USD

-0.020-1.75%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

30.66MMarket Cap

LossP/E TTM



AN2 Therapeutics Inc

1.120

-0.020-1.75%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of AN2 Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Total equity

Cash, cash equivalents and short-term investments

-33.72%61.92M

-39.82%62.92M

-41.28%67.06M

-22.07%83.62M

-24.55%93.43M

9.74%104.54M

29.03%114.21M

11.70%107.30M

18.62%123.82M

-15.99%95.26M

-25.21%88.52M

--96.06M

--104.38M

--113.39M

--118.35M

- Cash and cash equivalents

-46.27%18.00M

-31.94%18.22M

-19.07%19.98M

36.45%21.35M

2.72%33.50M

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

--27.22M

--28.80M

--40.62M

--82.52M

-Short-term investments

-26.71%43.92M

-42.53%44.70M

-47.41%47.08M

-32.06%62.27M

-34.30%59.92M

42.84%77.77M

44.84%89.52M

33.13%91.65M

20.67%91.20M

-25.18%54.45M

72.47%61.81M

--68.84M

--75.58M

--72.77M

--35.84M

Prepaid expenses

-50.86%2.10M

59.01%4.61M

18.83%2.50M

-17.68%2.64M

64.53%4.26M

-1.26%2.90M

19.02%2.10M

28.02%3.21M

-8.80%2.59M

-15.54%2.94M

26.49%1.77M

--2.51M

--2.84M

--3.48M

--1.40M

Other current assets

----

--0.00

----

-100.00%0.00

0.00%13.00K

6.25%34.00K

--53.00K

--73.00K

--13.00K

--32.00K

Total current assets

-34.47%64.02M

-37.15%67.52M

-40.20%69.56M

-21.94%86.26M

-22.72%97.69M

9.40%107.44M

28.78%116.31M

12.05%110.51M

17.81%126.41M

-15.97%98.21M

-24.60%90.32M

--98.62M

--107.30M

--116.88M

--119.78M

Non-current assets

Other non-current assets

--0.00

-100.00%0.00

-70.85%304.00K

-22.91%804.00K

-100.00%0.00

44.86%1.04M

35.81%1.04M

44.86%1.04M

0.00%720.00K

6.67%768.00K

--720.00K

Total non-current assets

--3.22M

695.88%8.30M

138.20%11.78M

-79.37%5.83M

-100.00%0.00

44.86%1.04M

544.14%4.95M

616.86%28.24M

910.29%27.40M

-77.06%720.00K

6.67%768.00K

--3.94M

--2.71M

--3.14M

--720.00K

Total assets

-31.17%67.23M

-30.10%75.83M

-32.92%81.34M

-33.63%92.09M

-36.49%97.69M

9.66%108.48M

33.13%121.26M

35.28%138.74M

39.82%153.81M

-17.57%98.93M

-24.41%91.08M

--102.56M

--110.01M

--120.02M

--120.50M

Liabilities

Current liabilities

-Other payables

-85.65%183.00K

28.26%717.00K

14.95%369.00K

18.77%791.00K

31.04%1.27M

--559.00K

--321.00K

--666.00K

--973.00K

----

Accrued expenses

-36.72%4.45M

-45.95%4.15M

-42.19%4.57M

-42.70%6.13M

-21.76%7.03M

-4.13%7.68M

58.75%7.91M

113.77%10.70M

208.69%8.99M

218.65%8.01M

104.52%4.98M

--5.00M

--2.91M

--2.52M

--2.44M

Other current liabilities

-85.65%183.00K

28.26%717.00K

14.95%369.00K

18.77%791.00K

31.04%1.27M

--559.00K

--321.00K

--666.00K

--973.00K

----

Total current liabilities

-31.54%6.86M

-31.05%6.98M

-24.84%8.01M

-27.10%10.24M

-32.50%10.02M

-9.26%10.13M

24.48%10.66M

95.42%14.04M

234.81%14.84M

169.00%11.16M

68.39%8.57M

--7.19M

--4.43M

--4.15M

--5.09M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Derivatives liabilities

----

-100.00%0.00

-75.00%1.00K

-83.33%1.00K

--2.00K

--3.00K

--4.00K

--6.00K

Other non-current liabilities

----

--0.00

----

Total non-current liabilities

----

-100.00%0.00

-75.00%1.00K

-83.33%1.00K

--2.00K

--3.00K

--4.00K

--6.00K

Total liabilities

-31.54%6.86M

-31.05%6.98M

-24.84%8.01M

-27.10%10.24M

-32.50%10.02M

-9.27%10.13M

24.47%10.66M

95.37%14.04M

234.59%14.84M

168.77%11.16M

68.21%8.57M

--7.19M

--4.43M

--4.15M

--5.09M

Shareholders' equity

Common equity

2.36%292.55M

2.75%291.70M

2.87%289.71M

3.12%287.59M

3.31%285.81M

36.01%283.89M

50.00%281.62M

50.37%278.88M

50.36%276.65M

14.21%208.73M

9.16%187.74M

--185.47M

--184.00M

--182.77M

--171.99M

Retained earnings

-17.14%-232.24M

-20.15%-222.89M

-26.51%-216.43M

-33.23%-205.78M

-44.12%-198.25M

-53.50%-185.51M

-62.85%-171.07M

-72.15%-154.46M

-76.62%-137.56M

-81.61%-120.85M

-86.18%-105.05M

---89.72M

---77.88M

---66.54M

---56.42M

Capital reserves

2.36%292.55M

2.75%291.70M

2.87%289.71M

3.12%287.59M

3.31%285.81M

36.01%283.89M

50.00%281.62M

50.37%278.88M

50.36%276.65M

14.21%208.73M

9.16%187.74M

--185.47M

--184.00M

--182.76M

--171.99M

Gains losses not affecting retained earnings

-42.86%64.00K

192.59%25.00K

-9.43%48.00K

-88.73%31.00K

191.80%112.00K

77.31%-27.00K

130.29%53.00K

173.53%275.00K

77.45%-122.00K

66.94%-119.00K

-10.76%-175.00K

---374.00K

---541.00K

---360.00K

---158.00K

Total equity

-31.13%60.38M

-30.01%68.84M

-33.70%73.33M

-34.36%81.85M

-36.91%87.67M

12.07%98.35M

34.03%110.60M

30.75%124.70M

31.63%138.97M

-24.25%87.76M

-28.50%82.52M

--95.37M

--105.57M

--115.86M

--115.41M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

